ABCB1 and ovarian carcinoma: This effect was mediated by repressing IMP-1, which in turn causes destabilization of multidrug resistance (MDR1) at the mRNA and protein level, thereby increasing the sensitivity of the multidrug-resistant ovarian cancer cell to Taxanes but not carboplatin, a non-MDR1 substrate (143).